ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Dermata Therapeutics Inc

Dermata Therapeutics Inc (DRMA)

1,33
-0,0262
(-1,93%)
Fermé 28 Décembre 10:00PM
1,27
-0,06
(-4,51%)
Après les heures de négociation: 1:11AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
1,27
Prix Achat
1,27
Prix Vente
1,32
Volume échangé
201 436
1,25 Fourchette du Jour 1,33
1,00 Plage de 52 semaines 13,35
Cap du marché
Clôture Veille
1,3562
Ouverture
1,32
Dernière Transaction
66
@
1.29
Dernière heure de transaction
Volume financier
US$ 261 647
VWAP
1,2989
Volume moyen (3 m)
318 345
Actions en circulation
2 040 768
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,35
Bénéfice par action (BPA)
-3,82
Chiffre d'affairess
-
Bénéfice net
-7,8M

À propos de Dermata Therapeutics Inc

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its p... Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Dermata Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker DRMA. Le dernier cours de clôture d'Dermata Therapeutics était de US$1,36. Au cours de la dernière année, les actions de Dermata Therapeutics ont été négociées dans une fourchette de prix de US$ 1,00 à US$ 13,35.

Dermata Therapeutics compte actuellement 2 040 768 actions en circulation. La capitalisation boursière d'Dermata Therapeutics est de US$2,77 million. Dermata Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.35.

DRMA Dernières nouvelles

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor...

Dermata Therapeutics to Present at the Life Sciences Investor Forum on Thursday, November 14, 2024

SAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Dermata Therapeutics, Inc. (Nasdaq: DRMA; DRMAW) (“Dermata” or the “Company”), a late-stage biotechnology company focused on the treatment of medical...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.1917.59259259261.081.411.066041271.25696437CS
40.1311.40350877191.141.4517023681.34153788CS
12-0.17-11.80555555561.441.6813183451.3632976CS
26-1.37-51.89393939392.645114419642.53530581CS
52-7.43-85.40229885068.713.3519488783.97870576CS
156-512.33-99.7527258567513.6588195760066.25621174CS
260-1390.73-99.9087643678139216681890396113.20660482CS

DRMA - Frequently Asked Questions (FAQ)

What is the current Dermata Therapeutics share price?
The current share price of Dermata Therapeutics is US$ 1,27
How many Dermata Therapeutics shares are in issue?
Dermata Therapeutics has 2 040 768 shares in issue
What is the market cap of Dermata Therapeutics?
The market capitalisation of Dermata Therapeutics is USD 2,77M
What is the 1 year trading range for Dermata Therapeutics share price?
Dermata Therapeutics has traded in the range of US$ 1,00 to US$ 13,35 during the past year
What is the PE ratio of Dermata Therapeutics?
The price to earnings ratio of Dermata Therapeutics is -0,35
What is the reporting currency for Dermata Therapeutics?
Dermata Therapeutics reports financial results in USD
What is the latest annual profit for Dermata Therapeutics?
The latest annual profit of Dermata Therapeutics is USD -7,8M
What is the registered address of Dermata Therapeutics?
The registered address for Dermata Therapeutics is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Dermata Therapeutics website address?
The website address for Dermata Therapeutics is www.dermatarx.com
Which industry sector does Dermata Therapeutics operate in?
Dermata Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
INTZIntrusion Inc
US$ 2,167
(381,56%)
187,57M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
557,72M
HUBCWHub Cyber Security Ltd
US$ 0,035
(250,00%)
2,65M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,75M
LITMSnow Lake Resources Ltd
US$ 1,61
(82,95%)
129,92M
NEUPNeuphoria Therapeutics Inc
US$ 4,11
(-92,30%)
940,73k
VIRXViracta Therapeutics Inc
US$ 0,16
(-32,49%)
9,47M
PRFXPainReform Ltd
US$ 3,48
(-28,98%)
949,52k
AIREreAlpha Tech Corporation
US$ 2,56
(-28,49%)
8,42M
AVGRAvinger Inc
US$ 0,9721
(-24,05%)
2,16M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
563,26M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,95M
RGTIRigetti Computing Inc
US$ 17,08
(10,62%)
305,79M
XTIAXTI Aerospace Inc
US$ 0,03935
(-1,63%)
268M
QSIQuantum Si Inc
US$ 3,585
(66,74%)
256,01M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock